Holen Sie sich die Stockscreener-App
1.93
2.27%
-0.05
Schlusskurs vom Vortag:
$1.98
Offen:
$1.92
24-Stunden-Volumen:
202.98K
Relative Volume:
0.46
Marktkapitalisierung:
$52.18M
Einnahmen:
$18.94M
Nettoeinkommen (Verlust:
$-2.71M
KGV:
-13.79
EPS:
-0.14
Netto-Cashflow:
$-4.92M
1W Leistung:
-12.05%
1M Leistung:
-19.71%
6M Leistung:
+20.19%
1J Leistung:
+20.94%
1-Tages-Spanne:
$1.90
$2.00
1-Wochen-Bereich:
$1.90
$2.21
52-Wochen-Spanne:
$1.18
$3.78
Icad Inc Stock (ICAD) Company Profile
Firmenname
Icad Inc
Sektor
Branche
Telefon
603-882-5200
Adresse
98 SPIT BROOK ROAD, SUITE 100, NASHUA, NH
Vergleichen Sie ICAD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICAD
Icad Inc
|
1.935 | 52.18M | 18.94M | -2.71M | -4.92M | -0.14 |
|
ABT
Abbott Laboratories
|
131.47 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.30 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
373.42 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.44 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.91 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Icad Inc Stock (ICAD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-01-18 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-22 | Eingeleitet | Guggenheim | Buy |
| 2021-03-23 | Eingeleitet | BTIG Research | Buy |
| 2021-02-26 | Eingeleitet | Oppenheimer | Outperform |
| 2021-01-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Eingeleitet | B. Riley Securities | Buy |
| 2020-02-05 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-01-09 | Eingeleitet | Lake Street | Buy |
| 2008-12-09 | Bestätigt | Canaccord Adams | Buy |
| 2008-08-01 | Bestätigt | MDB Capital Group | Buy |
| 2008-05-14 | Bestätigt | Canaccord Adams | Buy |
| 2008-02-14 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
| 2007-01-24 | Bestätigt | Dawson James | Speculative Buy |
Alle ansehen
Icad Inc Aktie (ICAD) Neueste Nachrichten
iCAD and RamSoft partner to enhance breast cancer detection with AI - Outsource Accelerator
ICAD targets SaaS growth with ProFound Cloud expansion and AI advancements - MSN
iCAD Inc. Earnings Call Highlights Growth and Challenges - TipRanks
iCAD, RamSoft to Deliver ProFound AI-Powered Mammography Solutions - Medical Product Outsourcing
iCAD, Inc. (NASDAQ:ICAD) Q4 2024 Earnings Call Transcript - Insider Monkey
iCAD (NASDAQ:ICAD) Issues Earnings Results - MarketBeat
iCAD, Inc. (NASDAQ:ICAD): Is Breakeven Near? - Yahoo Finance
iCAD Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
BTIG maintains Buy rating and $3 target on iCAD shares - Investing.com
BTIG maintains Buy rating and $3 target on iCAD shares By Investing.com - Investing.com UK
icad Inc (ICAD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic SaaS ... - Yahoo Finance
icad Inc (ICAD) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic SaaS Transition - GuruFocus.com
iCAD, Inc. Reports Strong Revenue Growth Amid SaaS Transition - TipRanks
Icad: Q4 Earnings Snapshot - mySA
Earnings call transcript: iCAD Q4 2024 beats EPS forecast, stock surges - Investing.com Australia
ICAD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
icad Inc (ICAD) Q4 2024 Earnings: EPS Loss of ($0.03) Beats Esti - GuruFocus
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 - TradingView
iCAD (ICAD) to Release Earnings on Wednesday - Defense World
iCAD (NASDAQ:ICAD) Shares Pass Above 200 Day Moving Average – Time to Sell? - Defense World
Advancing AI-Powered Breast Health Solutions to Transform Global Healthcare | Newswise - Newswise
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025 - The Manila Times
Key Earnings Date: AI Cancer Detection Leader iCAD Sets Q4 2024 Results Release - StockTitan
iCAD, Inc. to Host Earnings Call - ACCESS Newswire
iCAD (ICAD) Expected to Announce Earnings on Monday - Defense World
iCAD, RamSoft Integrate to Enhance AI Breast Cancer Detection - HIT Consultant
ICAD, RamSoft Collaborate to Enhance Breast Cancer Detection -March 05, 2025 at 03:20 pm EST - Marketscreener.com
iCAD, Inc. and RamSoft® Announce Strategic Integration Partnership to Enhance AI-Powered Breast Health Solutions Across North America - Nasdaq
iCAD and RamSoft Announce Partnership to Deliver ProFound® - GlobeNewswire
Can This AI Technology Catch the 40% of Breast Cancers That Mammograms Miss? - StockTitan
Investor Network: iCAD, Inc. to Host Earnings Call - ACCESS Newswire
iCAD, Inc. (ICAD) and Koios Partner to Enhance AI-Powered Breast Cancer Detection - Insider Monkey
iCAD, Inc. and Koios Medical Announce Strategic Partnership for AI-Powered Breast Cancer Detection Solutions - Nasdaq
Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025 - GlobeNewswire
Can This New AI Partnership Transform Breast Cancer Detection? iCAD Teams With Koios - Stock Titan
Artificial Intelligence (AI) in Breast Imaging Market to - GlobeNewswire
iCAD, Inc. (ICAD): A Bull Case Theory - Insider Monkey
iCAD, Inc. (ICAD) to Showcase AI-Powered Breast Health Innovations at ECR 2025 - Insider Monkey
9 AI News and Ratings on Wall Street’s Radar - Insider Monkey
iCAD To Showcase Five AI-Powered Research Presentations - GlobeNewswire
iCAD Shares Unchanged Ahead of Presentations - Baystreet.ca
Earnings call transcript: ICAD Q4 2024 shows strategic resilience By Investing.com - Investing.com Canada
Can AI Transform Breast Cancer Detection? iCAD's Revolutionary Research Answers Key Questions - StockTitan
iCAD (NASDAQ:ICAD) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
Finanzdaten der Icad Inc-Aktie (ICAD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):